Bergamo Acquisition Corp. (BGMO): VistaGen Therapeutics Board of Directors...

Reply Private New

Replies (3) Next 10 Prev Next

Send PM Follow Ignore

Followers	4
Posts	4327
Boards Moderated	0
Alias Born	12/11/2012

HighYieldInvestments

Re: HighYieldInvestments post# 39612

Tuesday, 08/20/2013 10:03:38 AM

Tuesday, August 20, 2013 10:03:38 AM

VistaGen Therapeutics Board of Directors APPROVED RECENT TRANSACTION

Jon S. Saxe,
Chairman

Brian J. Underdown, Ph.D.,
Director

H. Ralph Snodgrass, Ph.D.,
Founder, President and Chief Scientific Officer

Shawn K. Singh, J.D.
Chief Executive Officer

Management Team

Shawn K. Singh, J.D.
Chief Executive Officer, Director

H. Ralph Snodgrass, Ph.D.
Founder, President and Chief Scientific Officer, Director

Jerrold D. Dotson, CPA
Acting Chief Financial Officer

A. Franklin Rice, MBA
VP of Corporate Development, Secretary

Scientific Advisory Board

Gordon Keller, Ph.D.
Chairman, Director, McEwen Centre for Regenerative Medicine, University Health Network
DIRECTOR'S OF VSTA APPROVED RECENT TRANSACTION LIKE IT OR NOT

EXPERIENCE IS THE BEST TEACHER, BUT IT IS THE MOST EXPENSIVE
MY OPINIONS ARE MY OWN AND DUE DILIGENCE I POST SHOULD BE CONFIRMED AS UNBIASED,EVERYTHING POSTED IS OFCOURSE IN MY HUMBLE OPINION